|
1
|
Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy.
|
Hepatology
|
2011
|
4.60
|
|
2
|
Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma.
|
Hepatology
|
2005
|
2.50
|
|
3
|
The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria.
|
Am J Gastroenterol
|
2009
|
2.47
|
|
4
|
Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.
|
Ultrasound Med Biol
|
2012
|
2.39
|
|
5
|
Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis.
|
J Hepatol
|
2013
|
2.23
|
|
6
|
When to perform hepatic resection for intermediate-stage hepatocellular carcinoma.
|
Hepatology
|
2015
|
2.15
|
|
7
|
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression.
|
Liver Transpl
|
2005
|
2.04
|
|
8
|
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population.
|
Ann Surg Oncol
|
2008
|
1.98
|
|
9
|
Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions.
|
Semin Liver Dis
|
2013
|
1.85
|
|
10
|
Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound.
|
Liver Int
|
2013
|
1.57
|
|
11
|
Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas.
|
Hepatology
|
2011
|
1.50
|
|
12
|
Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
|
Liver Transpl
|
2005
|
1.30
|
|
13
|
Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy.
|
Liver Transpl
|
2011
|
1.22
|
|
14
|
Acoustic Radiation Force Impulse elastography for fibrosis evaluation in patients with chronic hepatitis C: an international multicenter study.
|
Eur J Radiol
|
2012
|
1.18
|
|
15
|
Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma.
|
J Hepatol
|
2008
|
1.11
|
|
16
|
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study.
|
Int J Cancer
|
2014
|
1.11
|
|
17
|
Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study.
|
J Hepatol
|
2010
|
1.06
|
|
18
|
Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines.
|
J Hepatol
|
2012
|
1.05
|
|
19
|
Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey.
|
J Hepatol
|
2013
|
1.04
|
|
20
|
Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma.
|
Dig Liver Dis
|
2013
|
1.02
|
|
21
|
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.
|
J Hepatol
|
2013
|
1.00
|
|
22
|
Expression of reelin in hepatic stellate cells and during hepatic tissue repair: a novel marker for the differentiation of HSC from other liver myofibroblasts.
|
J Hepatol
|
2002
|
0.99
|
|
23
|
Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography.
|
J Hepatol
|
2004
|
0.97
|
|
24
|
Contrast-enhanced ultrasound for liver imaging: recent advances.
|
Curr Pharm Des
|
2012
|
0.96
|
|
25
|
A benign tumour of the liver mimicking malignant liver disease--cholangiocellular adenoma.
|
Scand J Gastroenterol
|
2009
|
0.94
|
|
26
|
Characterization of liver lesions by real-time contrast-enhanced ultrasonography.
|
Eur J Gastroenterol Hepatol
|
2007
|
0.94
|
|
27
|
Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma.
|
World J Gastroenterol
|
2013
|
0.89
|
|
28
|
Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension?
|
J Vasc Interv Radiol
|
2013
|
0.89
|
|
29
|
Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation.
|
Liver Transpl
|
2009
|
0.89
|
|
30
|
Safety of ultrasound contrast agents in patients with known or suspected cardiac shunts.
|
Am J Cardiol
|
2013
|
0.88
|
|
31
|
Role of contrast-enhanced ultrasonography in primary hepatic lymphoma.
|
J Ultrasound Med
|
2010
|
0.88
|
|
32
|
Quantification of enhancement of focal liver lesions during contrast-enhanced ultrasound (CEUS). Analysis of ten selected frames is more simple but as reliable as the analysis of the entire loop for most parameters.
|
Eur J Radiol
|
2011
|
0.86
|
|
33
|
Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients.
|
Clin Cancer Res
|
2012
|
0.86
|
|
34
|
The influence of aminotransferase levels on liver stiffness assessed by Acoustic Radiation Force Impulse Elastography: a retrospective multicentre study.
|
Dig Liver Dis
|
2013
|
0.85
|
|
35
|
Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma.
|
Liver Cancer
|
2012
|
0.83
|
|
36
|
Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis.
|
J Hepatol
|
2005
|
0.82
|
|
37
|
Long-term effectiveness of radiofrequency ablation for solitary small hepatocellular carcinoma: a retrospective analysis of 363 patients.
|
Dig Liver Dis
|
2012
|
0.82
|
|
38
|
Detection of HCV antigens in liver graft: relevance to the management of recurrent post-liver transplant hepatitis C.
|
Liver Transpl
|
2006
|
0.81
|
|
39
|
Metronomic capecitabine in patients with hepatocellular carcinoma unresponsive to or ineligible for sorafenib treatment: report of two cases.
|
Hepat Mon
|
2013
|
0.81
|
|
40
|
Extracorporeal detoxification for hepatic failure using molecular adsorbent recirculating system: depurative efficiency and clinical results in a long-term follow-up.
|
Artif Organs
|
2013
|
0.81
|
|
41
|
The ART score is not effective to select patients for transarterial chemoembolization retreatment in an Italian series.
|
Dig Dis
|
2014
|
0.80
|
|
42
|
Use of VEGFR-2 targeted ultrasound contrast agent for the early evaluation of response to sorafenib in a mouse model of hepatocellular carcinoma.
|
Mol Imaging Biol
|
2015
|
0.80
|
|
43
|
Onset of bronchiolitis obliterans organizing pneumonia in a liver transplant recipient under peg-interferon and ribavirin treatment.
|
Intern Emerg Med
|
2008
|
0.80
|
|
44
|
In human hepatocellular carcinoma in cirrhosis proliferating cell nuclear antigen (PCNA) is involved in cell proliferation and cooperates with P21 in DNA repair.
|
J Hepatol
|
2003
|
0.79
|
|
45
|
Outcomes from a program of home care attendance in very frail elderly subjects.
|
Arch Gerontol Geriatr
|
2006
|
0.78
|
|
46
|
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy?
|
Clin Transplant
|
2009
|
0.77
|
|
47
|
Effect of Levovist on splanchnic hemodynamics in cirrhotic patients.
|
Ultrasound Med Biol
|
2003
|
0.76
|
|
48
|
Recent advances in the imaging of hepatocellular carcinoma. From ultrasound to positron emission tomography scan.
|
Saudi Med J
|
2007
|
0.76
|
|
49
|
Letter to the editor.
|
Ultraschall Med
|
2012
|
0.75
|
|
50
|
Down-staging of hepatocellular carcinoma prior to liver transplantation: the power of selection.
|
Hepatology
|
2009
|
0.75
|
|
51
|
Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice?
|
Ann Surg
|
2009
|
0.75
|
|
52
|
Reply to: "non-invasive diagnosis of small nodules in cirrhosis".
|
J Hepatol
|
2013
|
0.75
|
|
53
|
Portal pressure and Doppler.
|
Ultrasound Med Biol
|
2003
|
0.75
|
|
54
|
Yttrium 90 radioembolization: the horizon is changing for patients with intermediate and advanced hepatocellular carcinoma.
|
Hepatology
|
2013
|
0.75
|
|
55
|
Selecting patients with hepatocellular carcinoma for transplantation.
|
Liver Transpl
|
2007
|
0.75
|
|
56
|
A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma.
|
Dig Liver Dis
|
2011
|
0.75
|
|
57
|
Hepatic artery thrombosis and graft ischemia in the presence of preserved arterial inflow: not a contradiction but a real possibility.
|
Liver Transpl
|
2004
|
0.75
|
|
58
|
Echo-enhanced ultrasonography: is it the future gold standard of imaging in acute pancreatitis?
|
JOP
|
2005
|
0.75
|
|
59
|
Validation of noninvasive methods for the assessment of liver fibrosis in patients with recurrent hepatitis C after transplantation.
|
Liver Transpl
|
2010
|
0.75
|
|
60
|
Development and validation of a nomogram based on clinical factors and standard laboratory tests for prediction of clinically significant liver fibrosis in chronic hepatitis C virus infection.
|
Eur J Gastroenterol Hepatol
|
2013
|
0.75
|
|
61
|
Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosis.
|
Clin Gastroenterol Hepatol
|
2006
|
0.75
|